Sotero P Romero

  • Citations Per Year
Learn More
BACKGROUND Data on the incidence and mortality of heart failure (HF) in community-based populations of developed countries are limited. We estimated the trends of the incidence and, the mortality of HF. METHODS Prospective population-based study in a white, low-middle class Mediterranean community of 267,231 inhabitants in Spain. Participants were all the(More)
OBJECTIVE To assess the effect of the commencement of metformin therapy (CMet) on the prognosis of patients with newly diagnosed heart failure (HF) and new-onset diabetes mellitus (DM) treated with a contemporary medical regimen. METHODS Prospective study of 1519 HF patients with DM during 9 years. Mean age was 71.7+/-7.8 years, 817 (53.8%) were women,(More)
OBJECTIVES To assess the incidence of type 2 diabetes mellitus (DM) in patients with heart failure (HF), and to evaluate the effect of new-onset DM and glycemic control on the prognosis of HF patients treated with a contemporary medical regimen. METHODS Prospective study of 5314 HF patients and previously unknown DM during 9 years. Their mean age was 71.8(More)
BACKGROUND AND OBJECTIVE To evaluate if consultation between specialists in Internal Medicine and family doctors (CIMFD) improves the clinical management and prognosis of patients with heart failure (HF). METHODS DESIGN prospective case-control study (5 years of follow-up). SETTING community-based sample within the area of a university teaching(More)
BACKGROUND The role of digoxin in the prognosis of patients with heart failure (HF) remains unclear. AIMS To evaluate the relationship of commencing treatment with digoxin (CTDig) with the mortality and the morbidity of patients with HF. METHODS Prospective study over 8 years on 4467 patients with HF. Main outcomes were all-cause and cardiovascular(More)
BACKGROUND The effect of treatment with statins on the prognosis of newly diagnosed heart failure (ndHF) is not established. We evaluate the relationship of commencing treatment with statins (CTS) with the mortality and the morbidity of ndHF, systolic (HF-DSF) and non-systolic (HF-PSF). METHODS Prospective propensity-adjusted cohort study over 5 years on(More)
BACKGROUND Studies on the safety of amiodarone therapy in heart failure (HF) presented conflicting results. We evaluated the relationship of commencing treatment with amiodarone (CTA) with the mortality and the morbidity of patients newly diagnosed with HF. METHODS Prospective cohort study over 7 years on 3734 patients with HF. Main outcomes were(More)
BACKGROUND The effect of treatment with β-blockers on the prognosis of patients newly diagnosed with heart failure with preserved systolic function (HF-PSF) is unknown. OBJECTIVES To analyze the relationship of commencing treatment with the β-blockers bisoprolol or carvedilol (CT-βB) with the mortality and the morbidity of newly diagnosed HF-PSF. (More)
BACKGROUND The effect of treatment with angiotensin-converting enzyme inhibitors (ACEIs) on the prognosis of patients newly diagnosed with heart failure with preserved systolic function (HF-PSF) is unclear. We evaluate the relationship of commencing ACEI therapy (C-ACEI-T) with the morbidity and mortality of patients with HF-PSF. METHODS Prospective(More)
BACKGROUND The effect of treatment with β-blockers on the prognosis of patients newly diagnosed with heart failure with preserved ejection fraction (HFpEF) is unknown. OBJECTIVE To analyze the relationship of commencing treatment with the β-blockers bisoprolol or carvedilol (CT-βB) with the prognosis of newly diagnosed HFpEF. METHODS Prospective study(More)